• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

简易健康量表:一种用于克罗恩病主观健康评估的有效、可靠且灵敏的工具。

Short health scale: a valid, reliable, and responsive instrument for subjective health assessment in Crohn's disease.

作者信息

Stjernman Henrik, Grännö Christer, Järnerot Gunnar, Ockander Leif, Tysk Curt, Blomberg Björn, Ström Magnus, Hjortswang Henrik

机构信息

Division of Gastroenterology, Department of Medicine, County Hospital Ryhov, Jönköping; Sweden.

出版信息

Inflamm Bowel Dis. 2008 Jan;14(1):47-52. doi: 10.1002/ibd.20255.

DOI:10.1002/ibd.20255
PMID:17828783
Abstract

BACKGROUND

Health-related quality of life (HRQoL) is an essential part of inflammatory bowel disease (IBD) assessment. The Short Health Scale (SHS), an HRQoL questionnaire in which the patients rate the disease impact on 4 important aspects of subjective health (symptoms, function, worry, and general well-being) was demonstrated in a previous study to be valid, reliable, and responsive in patients with ulcerative colitis. The present study evaluates the SHS in patients with Crohn's disease (CD).

METHODS

In all, 367 CD patients completed the SHS and 4 other HRQoL questionnaires (IBDQ, SF-36, RFIPC, and PGWB) at their regular outpatient visits. Then 330 patients completed the questionnaires at a second visit 6 months later. In addition, reliability data were obtained from repeat measurements 4 weeks after the first visit in 40 patients stable in remission.

RESULTS

Patients in remission scored better on all 4 questions than those with active disease (P < 0.001). All 4 questions were strongly correlated with the corresponding dimensions of the other HRQoL questionnaires (r(s) = 0.74-0.83). Reliability was confirmed with strong test-retest correlations (r(s) = 0.69-0.82) and intraclass correlation coefficients (0.66-0.77). Patients who changed from remission to active disease or vice versa showed a significant change in all 4 SHS scores (P < 0.005).

CONCLUSIONS

SHS is a valid, reliable and responsive HRQoL instrument also in patients with CD. It is easily completed by the patient and requires no further calculation by the investigator. SHS gives a comprehensive overview of the main aspects of the patient's subjective health perception and is a useful tool in both clinical practice and clinical studies.

摘要

背景

健康相关生活质量(HRQoL)是炎症性肠病(IBD)评估的重要组成部分。简短健康量表(SHS)是一种HRQoL问卷,患者可对疾病对主观健康的4个重要方面(症状、功能、担忧和总体幸福感)的影响进行评分。先前一项研究表明,该量表在溃疡性结肠炎患者中具有有效性、可靠性和反应性。本研究对克罗恩病(CD)患者进行SHS评估。

方法

共有367例CD患者在定期门诊就诊时完成了SHS及其他4种HRQoL问卷(IBDQ、SF - 36、RFIPC和PGWB)。然后,330例患者在6个月后的第二次就诊时完成了这些问卷。此外,从40例病情稳定处于缓解期的患者首次就诊4周后的重复测量中获得了可靠性数据。

结果

缓解期患者在所有4个问题上的得分均高于活动期患者(P < 0.001)。所有4个问题与其他HRQoL问卷的相应维度均呈强相关(r(s) = 0.74 - 0.83)。通过强重测相关性(r(s) = 0.69 - 0.82)和组内相关系数(0.66 - 0.77)证实了可靠性。从缓解期转变为活动期或反之的患者在所有4个SHS得分上均有显著变化(P < 0.005)。

结论

SHS在CD患者中也是一种有效、可靠且具有反应性的HRQoL工具。患者易于完成,研究者无需进一步计算。SHS全面概述了患者主观健康感知的主要方面,是临床实践和临床研究中的有用工具。

相似文献

1
Short health scale: a valid, reliable, and responsive instrument for subjective health assessment in Crohn's disease.简易健康量表:一种用于克罗恩病主观健康评估的有效、可靠且灵敏的工具。
Inflamm Bowel Dis. 2008 Jan;14(1):47-52. doi: 10.1002/ibd.20255.
2
Short health scale: A valid measure of health-related quality of life in Korean-speaking patients with inflammatory bowel disease.短健康量表:一种用于评估韩语炎性肠病患者健康相关生活质量的有效测量工具。
World J Gastroenterol. 2017 May 21;23(19):3530-3537. doi: 10.3748/wjg.v23.i19.3530.
3
The Short Health Scale: a valid and reliable measure of health related quality of life in English speaking inflammatory bowel disease patients.短健康量表:一种在讲英语的炎症性肠病患者中测量健康相关生活质量的有效且可靠的方法。
J Crohns Colitis. 2013 Sep;7(8):616-21. doi: 10.1016/j.crohns.2012.07.030. Epub 2012 Aug 21.
4
The Short Health Scale: a valid measure of subjective health in ulcerative colitis.简易健康量表:溃疡性结肠炎主观健康状况的有效测量工具。
Scand J Gastroenterol. 2006 Oct;41(10):1196-203. doi: 10.1080/00365520600610618.
5
Short health scale: a valid, reliable, and responsive measure of health-related quality of life in children with inflammatory bowel disease.简易健康量表:一种用于评估炎症性肠病患儿健康相关生活质量的有效、可靠且灵敏的测量工具。
Inflamm Bowel Dis. 2015 Apr;21(4):818-23. doi: 10.1097/MIB.0000000000000324.
6
Validation of the mainland Chinese version of the Inflammatory Bowel Disease Questionnaire (IBDQ) for ulcerative colitis and Crohn's disease.中国大陆版炎症性肠病问卷(IBDQ)用于溃疡性结肠炎和克罗恩病的效度验证。
Inflamm Bowel Dis. 2007 Jul;13(7):903-10. doi: 10.1002/ibd.20128.
7
Evaluation of the Inflammatory Bowel Disease Questionnaire in Swedish patients with Crohn's disease.炎症性肠病问卷在瑞典克罗恩病患者中的评估
Scand J Gastroenterol. 2006 Aug;41(8):934-43. doi: 10.1080/00365520500529488.
8
The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn's Relapse Prevention Trial.《简短炎症性肠病问卷:用于社区医生管理炎症性肠病的生活质量工具》。CCRPT研究人员。加拿大克罗恩病复发预防试验。
Am J Gastroenterol. 1996 Aug;91(8):1571-8.
9
Development and Validation of a Questionnaire to Assess the Quality of Life in Patients with Inflammatory Bowel Disease in Mainland China.中国大陆炎症性肠病患者生活质量评估问卷的研制与验证
Inflamm Bowel Dis. 2017 Mar;23(3):431-439. doi: 10.1097/MIB.0000000000001024.
10
Validity, reliability, and responsiveness of the EQ-5D in inflammatory bowel disease in Germany.德国炎症性肠病患者 EQ-5D 量表的有效性、可靠性和反应度。
Inflamm Bowel Dis. 2010 Jan;16(1):42-51. doi: 10.1002/ibd.20989.

引用本文的文献

1
Cohort profile: the Swedish Inception Cohort in inflammatory bowel disease (SIC-IBD).队列简介:瑞典炎症性肠病初始队列(SIC-IBD)。
BMJ Open. 2025 May 6;15(5):e099218. doi: 10.1136/bmjopen-2025-099218.
2
Translation and validation of Indonesian hemorrhoidal disease symptom score (HDSS) and short health scale hemorrhoidal disease (SHSHD).印度尼西亚痔病症状评分(HDSS)和痔病简短健康量表(SHSHD)的翻译与验证。
Turk J Surg. 2023 Dec 29;39(4):336-343. doi: 10.47717/turkjsurg.2023.6148. eCollection 2023 Dec.
3
Construct validity of EQ-5D-5L among patients with inflammatory bowel disease-a study based on real-world data from the Swedish Inflammatory Bowel Disease Registry.
炎症性肠病患者 EQ-5D-5L 的结构效度——基于瑞典炎症性肠病登记处真实世界数据的研究。
J Patient Rep Outcomes. 2024 Mar 27;8(1):39. doi: 10.1186/s41687-024-00709-9.
4
Effects of COVID-19 vaccines on patient-reported outcomes in patients with inflammatory bowel disease: a multicenter survey study in Korea.新型冠状病毒肺炎疫苗对炎症性肠病患者自我报告结局的影响:韩国一项多中心调查研究
Intest Res. 2024 Jul;22(3):336-350. doi: 10.5217/ir.2023.00077. Epub 2024 Mar 26.
5
Inflammatory Bowel Disease Disability Index is a valid and reliable measure of disability in an English-speaking hospital practice and predicts long-term requirement for treatment escalation.炎症性肠病残疾指数是一种在英语国家医院实践中对残疾情况进行有效且可靠评估的指标,并且能够预测长期治疗升级的需求。
Frontline Gastroenterol. 2023 Nov 10;15(2):130-136. doi: 10.1136/flgastro-2023-102428. eCollection 2024 Mar.
6
Rifaximin Treatment of Collagenous Colitis: A Randomised, Double-Blind, Placebo-Controlled Trial.利福昔明治疗胶原性结肠炎:一项随机、双盲、安慰剂对照试验。
Inflamm Intest Dis. 2024 Jan 24;9(1):22-28. doi: 10.1159/000536124. eCollection 2024 Jan-Dec.
7
A rapid, non-invasive, clinical surveillance for CachExia, sarcopenia, portal hypertension, and hepatocellular carcinoma in end-stage liver disease: the ACCESS-ESLD study protocol.一种用于终末期肝病患者的 CachExia、肌少症、门静脉高压和肝细胞癌的快速、非侵入性、临床监测:ACCESS-ESLD 研究方案。
BMC Gastroenterol. 2023 Dec 21;23(1):454. doi: 10.1186/s12876-023-03093-8.
8
Validation of the German version of the Short Health Scale - a brief, valid and reliable instrument to assess health-related quality of life in German-speaking patients with inflammatory bowel diseases.短健康量表德语版的验证 - 一种简短、有效和可靠的工具,用于评估德语国家炎症性肠病患者的健康相关生活质量。
Z Gastroenterol. 2023 Sep;61(9):1207-1213. doi: 10.1055/a-1976-9971. Epub 2023 Jan 10.
9
Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial.联合治疗中克罗恩病患者停用英夫利昔单抗或同时免疫抑制剂治疗(SPARE):一项多中心、开放标签、随机对照试验。
Lancet Gastroenterol Hepatol. 2023 Mar;8(3):215-227. doi: 10.1016/S2468-1253(22)00385-5. Epub 2023 Jan 11.
10
The Short Health Scale: A Valid and Reliable Quality-of-Life Scale for Mainland Chinese Patients with Inflammatory Bowel Disease.简易健康量表:一种适用于中国大陆炎症性肠病患者的有效且可靠的生活质量量表。
Palliat Med Rep. 2022 Aug 18;3(1):154-161. doi: 10.1089/pmr.2021.0066. eCollection 2022.